The Real Cost of Reactive Medical Device Supply Chain Risk
Reactive procurement is costing medical device makers millions. See what the Medline recall and FDA shortage list reveal about supply chain risk.
Read articleStrategic perspectives for CPOs, VP Procurement, and senior procurement leaders on building resilient supply chains, elevating procurement’s role in finance, and leading through disruption.
Reactive procurement is costing medical device makers millions. See what the Medline recall and FDA shortage list reveal about supply chain risk.
Read article
Pharma supply chain risk is now a board-level exposure. How CPOs can run supplier risk like a finance function in 2026, continuously…
Read article